The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired
The FDA has granted market clearance to Cedara Software's Web-enabled viewer, part of its Software for the Heart suite (HNN 10/18/00). The application enables clinicians to capture, retrieve, display, measure, and report on images acquired from multiple modalities (such as x-ray, echocardiography, and CT). The viewer supports both static and dynamic (cine) views and has a plug-in architecture, enabling integration of the viewer into other, third-party, products. The Canadian company plans to develop noncardiology applications for the viewer as well.
© 2000 Miller Freeman Inc.
12/13/00, Issue # 118, page 5.
Considering Breast- and Lesion-Level Assessments with Mammography AI: What New Research Reveals
June 27th 2025While there was a decline of AUC for mammography AI software from breast-level assessments to lesion-level evaluation, the authors of a new study, involving 1,200 women, found that AI offered over a seven percent higher AUC for lesion-level interpretation in comparison to unassisted expert readers.